Stay updated on Inhaled Imatinib for PAH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page
- CheckyesterdayChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, representing a minor update to the page's revision metadata rather than changes to the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a small update to the page version and metadata. No study data or content changes are indicated.SummaryDifference0.0%

- Check30 days agoChange DetectedThe study record for NCT05036135 shows termination with a note that AV-101 inhaled imatinib did not prove efficacy at any dose; the termination statement is included in the Study Details with the last update posted on 2024-08-23.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check65 days agoChange DetectedUI/layout updates and metadata refresh were observed; no core study details appear to have changed.SummaryDifference0.0%

- Check73 days agoChange DetectedThe core study details appear unchanged; only visual/layout differences are visible.SummaryDifference0.0%

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.